The Oligonucleotide Synthesis Market To Move Beyond Rigidity Backed By Innovation (US$ 540 Million) Between 2025

The Oligonucleotide Synthesis Market is expected to be worth US$ 540 Million at a CAGR of 13.9% between 2025. Healthcare is going the “digital” way. In other words, artificial intelligence (AI)-enabled medical devices and telemedicine are the concrete instances of the proliferation of the digital wave in the healthcare industry. This factor would be the one traversing the healthcare vertical in the forecast period.

Oligonucleotides are short fragments of nucleic acids and play a major role in drug discovery and molecular diagnostic chip technology. Oligonucleotide synthesis occurs either commercially to provide services for various end users or individually via DNA synthesizers for self-consumption.

Want Insights To Oligonucleotide Synthesis Market? Ask For Sample! https://www.persistencemarketresearch.co/samples/3296

The achievements of life sciences researchers and scientists in the recent years have expanded the understanding of biological systems at the molecular level, which has generated more opportunities and growth in life sciences research and applications.

Company Profiles

Integrated DNA Technologies, Inc.
GenScript Biotech Corporation
Eurofins Scientific SE
Bioneer Corporation
Kaneka Corporation (Eurogentec)
Biolegio B.V.
Eton Bioscience, Inc.
IBA GmbH
Quintara Biosciences
LGC Biosearch Technologies
Thermo Fisher Scientific, Inc.
TriLink BioTechnologies, LLC
TAG Copenhagen A/S
PolyGen GmbH
General Electric Co.
BioAutomation
Biolytic Lab Performance Inc

Planning To Conclude Your Strategy On A Decisive Note In The Oligonucleotide Synthesis Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.co/methodology/3296

Thus, there are continuous growth opportunities for key players in the global oligonucleotide synthesis market. A new research report by Persistence Market Research titled ‘Oligonucleotide Synthesis Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025’ presents a complete overview of the global oligonucleotide synthesis market.

According to the forecast, the global oligonucleotide synthesis market is expected to reach a market value of over US$ 770 Mn by 2025. The global market is expected to grow at an exceptional rate with a CAGR of 13.9% during the forecast period.

Global Oligonucleotide Synthesis Market: Drivers

Primarily the global oligonucleotide synthesis market is helped by the increase in research activities all over the world. The government is also supporting the research processes taking place especially in the healthcare sector. Government initiatives aimed towards attracting foreign players by providing various grants and subsidies are expected to boost the entry of major market players in emerging countries, thereby driving the regional markets.

The market also has a systematic distribution channel that helps in maintaining the proper flow of products in the market, which in turn helps in improving the demand for oligonucleotide synthesis.

However, the lack of a proper regulatory framework in emerging markets for pharmaceutical and molecular research activities is likely to hamper market revenue growth as the research activities for therapeutic applications of oligonucleotides also need to follow certain regulatory guidelines and absence of these guidelines restricts therapeutic research activities. This is expected to have a negative impact on the oligonucleotide synthesis market.

How About Knowing The Product/Technology Driving The Oligonucleotide Synthesis Market Before Investing Therein? Click The “Purchase Now” Button Of Our Oligonucleotide Synthesis Market Report! https://www.persistencemarketresearch.com/checkout/3296

Global Oligonucleotide Synthesis Market: Segmental Analysis

Based on Region, Asia Pacific is expected to dominate the global oligonucleotide synthesis market with a robust growth rate of 9.8% during the forecast period. However North America is expected to hold the maximum market value during the study period.

Based on Service Type, the custom oligonucleotide synthesis segment is expected to lead the global market during the forecast period.

On the basis of Application, the academic R&D segment dominates the global oligonucleotide synthesis market in terms of revenue with the highest growth rate and revenue share. The academic R&D segment is expected to witness a CAGR of 8.4% during the forecast period.

On the basis of End Users, the academic and research institutes segment dominates the global oligonucleotide synthesis market. The biopharmaceuticals companies segment is also expected to grow at a rate similar to academic and research institutes.

'PMR' Exclusive Reports-

Gastrointestinal Stromal Tumor Market: https://www.persistencemarketresearch.com/market-research/gastrointestinal-stromal-tumor-market.asp

Sds Poly Acrylamide Gel Electrophoresis Market: https://www.persistencemarketresearch.com/market-research/sds-poly-acrylamide-gel-electrophoresis-market.asp

Single Use Bioprocess System Market: https://www.persistencemarketresearch.com/market-research/single-use-bioprocess-system-market.asp

Growth Factors Market: https://www.persistencemarketresearch.com/market-research/growth-factors-market.asp

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

This release was published on openPR.